Advancements in Recombinant Human Serum Albumin for Biopharmaceutical Applications
Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising enhancements throughout different healthcare and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, much more dependable alternate for therapeutic use